PARLIAMENTARY WRITTEN QUESTION
(6 February 2025)
Question Asked
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution by the hon. Member for Havant of 3 February 2025, Official Report, column 552, for what reason the letter from AstraZeneca of 9 July 2025 to the Chancellor of the Exchequer and the Secretary of State for Science, Innovation and Technology received a delayed response.
Asked by:
Clive Jones (Liberal Democrat)
Asked by:
Clive Jones (Liberal Democrat)
Answer
The Government has had numerous discussions with AstraZeneca about their proposed investment into Speke. There were minor delays in replying to correspondence following the election period.
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.